GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Capex-to-Revenue

G Medical Innovations Holdings (G Medical Innovations Holdings) Capex-to-Revenue : 0.15 (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

G Medical Innovations Holdings's Capital Expenditure for the six months ended in Dec. 2022 was $-0.33 Mil. Its Revenue for the six months ended in Dec. 2022 was $2.20 Mil.

Hence, G Medical Innovations Holdings's Capex-to-Revenue for the six months ended in Dec. 2022 was 0.15.


G Medical Innovations Holdings Capex-to-Revenue Historical Data

The historical data trend for G Medical Innovations Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Capex-to-Revenue Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Revenue
Get a 7-Day Free Trial 0.77 0.08 0.10 0.11 0.48

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 - - 0.81 0.15

Competitive Comparison of G Medical Innovations Holdings's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Capex-to-Revenue falls into.



G Medical Innovations Holdings Capex-to-Revenue Calculation

G Medical Innovations Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.121) / 4.42
=0.48

G Medical Innovations Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.33) / 2.196
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (OTCPK:GMVDF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


G Medical Innovations Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Executives
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022

G Medical Innovations Holdings (G Medical Innovations Holdings) Headlines

From GuruFocus